The concepts in this article came from research done on the internet and will suggest the
possibility that the amino acid residues identified in the article that are in domain 1 of
Hypervarible region one and domains two and three of Hypervarible region 2 contain the
epitopes of the E2 glycoprotein that binds to the protiens CD81 and SR-B1 as well as
explaining the relationship between occuldin and CD81. It will also explain why the first
domain of the E2 glycoprotein binds to SR-B1.   This article will also explain the use of
disulphide bridges in E2 that devide each area of its amino acid complexes that coinside
with the pairing of CD81 and occuldin. That though this article suggest that these are the
eptopes of E2
in HCV needed for the creation of a recombinate vaccine no experimental data has been
collected thus no true methodology presented in this research because of the lack of
availability to a laboratory. Thus this essay is a research proposal for testing  That if the concepts derived from the research are right
and tested after this article is published, the article may help virologist studing
Hepatititis type C to develop a recombinate vaccine for the disease after the concepts in
the article are tested with the correct proceedures to thus not only serve as a base for a
recombinate vaccine but also provide the proper methodology to identify these amino acid
residues so that a complete essay on how to prevent HCV infection.